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Abstract: The neural protein -synuclein aggregates both in vivo and in vitro to form insoluble fibrils that are involved in 
Parkinson’s disease pathogenesis. We have generated -synuclein/fluorescent-protein fusion constructs overexpressed in 
muscle cells of the nematode, Caenorhabdtis elegans. Green Fluorescent Protein (GFP) variants, Cerulean (C) or Venus 
(V), were fused to the C-terminus of human -synuclein (S); the resultant fusion genes were designated SV and SC, plus a 
CV fusion as well as S, C and V singly. The aggregation behavior of the purified fusion proteins (expressed in E. coli) will be 
described elsewhere. These constructs were fused to a C. elegans unc-54 myosin promoter, and integrated transgenic lines 
generated by microinjection, -irradiation, and outcrossing of fluorescent progeny. All transgenic lines expressing -
synuclein showed significant reductions (p < 0.05) in lifespan, motility and pharyngeal pumping, as compared to wild-
type worms or lines expressing CFP and/or YFP only. We showed that CFP and YFP labels colocalised in granular 
inclusions throughout the body wall in transgenic lines expressing both SC and SV fusions (SC+SV), whereas SV+C 
worms displayed YFP-labelled inclusions on a diffuse CFP background. These findings implied that the -synuclein 
moieties of these fusion proteins still aggregated together in vivo, whereas CFP or YFP moieties alone did not. This in 
turn suggested that Foerster Resonanace Energy Transfer (FRET) between CFP and YFP labels in -synuclein aggregates 
could allow the extent of aggregation to be quantified. Accordingly, we also showed that net FRET signals increased 2-
fold between L4 and adult SC+SV worms. 
Keywords: Caenorhabditis elegans, CFP and YFP reporters, FRET, protein aggregation, -synuclein, transgenic strains. 
INTRODUCTION 
 Certain proteins have a propensity to aggregate both in 
vivo and in vitro, leading ultimately to the formation of 
fibrillar aggregates (amyloid fibrils), which are a typical 
pathological feature of several important neurodegenerative 
diseases, such as Alzheimer’s and Parkinson’s [1, 2]. These 
large fibrillar aggregates may well be the end result rather 
than the cause of neuronal toxicity and cell death, since 
several recent studies implicate smaller protein oligomers as 
the key neurotoxic species [3]. The characteristic extra- or 
intra-cellular aggregates observed in Lewy bodies or in 
dopaminergic neurons within the substantia nigra in 
Parkinson’s disease patients [4] are principally composed of 
a small, natively unfolded neural protein called -synuclein 
[5], which was first linked to the disease through two mutant 
variants (A53T or A30P) that cause autosomal dominantly 
inherited forms of the disease [6, 7]. However, generating 
suitable animal models of Parkinson’s disease has proved 
problematic in several respects [8], and several groups have 
resorted to simplified invertebrate models that mimic only 
certain aspects of the disease, e.g. in Drosophila [9, 10]. 
Typical among these are several transgenic Caenorhabditis 
elegans models overexpressing human -synuclein in 
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various cell types, e.g. in body-wall muscle [11, 12], pan-
neuronally or else in dopaminergic neurons only [13]. The 
principal advantages of performing such studies in the C. 
elegans model [14] include its small size, transparency and 
anatomical simplicity, combined with its rapid development 
(3.5 days from egg to adult at 25
o
C), excellent genetics [15], 
reproduction predominantly by hermaphrodite self-fertili-
sation (allowing easy maintenance of mutant or transgenic 
stocks), straightforward production of transgenic lines [16, 
17], complete genome sequence [18], and genome-wide 
RNA interference (RNAi) by feeding [19]. Transgenic GFP 
reporter strains of C. elegans allow direct monitoring of gene 
expression levels in living worms [20], a feature which has 
been exploited in strains expressing -synuclein:GFP fusion 
proteins (such as the unc-54::-synuclein:YFP construct in 
strain NL5901 [12, 21]). 
 The present study follows this well-established 
precedent, but with a novel twist. We have co-injected N2 
worms with a mixture of unc-54::-synuclein:CFP (-
synuclein fused at its C-terminus with the blue or Cyan 
variant of GFP; henceforward this fusion is designated SC) 
and unc-54::-synuclein:YFP (-synuclein similarly fused to 
the yellow or Venus variant of GFP; this fusion is designated 
SV), generating an integrated double transgenic strain that 
expresses both CFP and YFP fusion proteins (unc-
54::SC+SV). In vitro aggregation studies using these same 
fusion proteins (expressed in E. coli) are being published 
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separately. Since CFP emissions overlap with YFP excitation 
wavelengths, this combination of fluorescent tags allows the 
progress of -synuclein aggregation to be monitored via 
Foerster Resonance Energy Transfer (FRET), whereby the 
donor CFP is excited at ~450 nm but emissions are read in 
the acceptor YFP range (~540 nm) [22]. Such FRET signals 
arise from donor CFP emissions exciting a nearby acceptor 
YFP molecule, which can only happen when the two 
fluorescent tags are in very close proximity (within about 70 
Angstroms [22]) – effectively, within the same protein 
aggregate rather than free in cytosolic solution. However, 
cross-over between the CFP and YFP channels is inevitable 
(particularly for CFP signals in the YFP emission range), and 
this needs to be corrected for in any FRET-based assay (see 
Methods). To maximize expression of both fluorescent tags 
attached to -synuclein, we chose to drive these constructs 
with the unc-54 major myosin promoter, ensuring abundant 
expression of both fusion proteins within the body wall 
muscle. A series of other transgenic strains was also 
constructed using the same unc-54 promoter, expressing CFP 
(C), YFP (V), -synuclein (S) and various fusion proteins 
(SC and SV), either alone or in combination. This paper 
reports a preliminary characterization of these strains in 
terms of simple life history parameters such as 
developmental time, brood size, motility, pharyngeal 
pumping rate and lifespan, as well as monitoring -synuclein 
aggregation during early adult life. 
MATERIALS AND METHODS 
Construction of Transgenic Strains 
 N2 and NL5901 (essentially an integrated -
synuclein:YFP fusion construct driven by the unc-54 
promoter [12]) strains of C. elegans were obtained from the 
Caenorhabditis Genetics Center (University of Minnesota, 
USA; funded by the NIH National Center for Research 
Resources). All transgenes generated in this study are listed 
in Table 1, and the design strategy is outlined in Fig. (1). 
Essentially, the human -synuclein coding sequence (here 
designated S) [23] was fused at its C-terminus to either 
Cerulean (cyan CFP; designated C) [24] or Venus (yellow 
YFP, designated V) [25] variants of GFP, with no added 
linker apart from 2 amino acids (phe-glu) introduced by the 
cloning site. Transgenic worms carrying the desired gene of 
interest were produced by micro-injection of recombinant 
DNA (100 ng μl-1 of each plasmid; < 1 ng per worm) into the 
worm gonad, where they were transferred as extra-
chromosomal arrays to unfertilized eggs. The fluorescent 
protein tags served as markers here, indicating which worms 
were transgenic. Transmitting lines for the various 
transgenes of interest were obtained and maintained by 
selection of fluorescent worms. Strains with stable 
chromosomally integrated transgenes were obtained by -
irradiation at 2000-4000 rads (gamma cell unit with a 
137
Caesium source; Nordion International Inc). Progeny of 
irradiated worms were screened for 100% transmission of 
transgenes and then outcrossed 5 times with wild-type N2 to 
remove deleterious mutations elsewhere in the genome. 
These procedures followed standard Wormbook protocols 
for generating integrated transgenic lines of C. elegans [26].  
 
Worms were cultured on standard Nematode Growth 
Medium (NGM) agar plates using a lac-deleted strain of E. 
coli (P90C) as food source, as described previously [27]; all 
worm washing and handling used K medium (53 mM NaCl, 
32 mM KCl [28]) throughout. 
 For initial cloning of fusion genes, Cerulean (CFP, C), 
Venus (YFP, V) and synuclein (S) were PCR amplified and 
cloned into pGEMT Easy with restriction sites added to the 
ends as follows: 
• NcoI-Cerulean-SacI 
• NcoI-Venus-SacI 
• NcoI-Synuclein-SacI 
• NcoI-Cerulean-Csp45I 
• NcoI-Synuclein-Csp45I 
• Csp45I-Cerulean-SacI 
• Csp45I-Venus-SacI 
 Clones were sequenced to exclude the possibility of 
PCR-induced mutations. Cloned genes were then excised 
from pGEMT Easy using the restriction enzymes listed 
above, and ligated into pET-30a either singly or in pairs. 
pET-30a was double digested with NcoI and SacI prior to 
ligation. For double ligations, NcoI-gene-Csp45I and 
Csp45I-gene-SacI were simultaneously ligated into pET-30a 
to produce gene fusions. They were further subcloned into 
pPD 30.38 (Addgene Fire lab vector). The following 
products were subcloned into pPD 30.38 in this way: 
• Cerulean   C 
• Venus   V 
• Synuclein   S 
• Cerulean-Venus  CV 
• Synuclein-Cerulean SC 
• Synuclein-Venus  SV 
Egg to Adult Development Time 
 The egg to adult development time of worms was 
monitored by picking individual hermaphrodites at the late 
L4 stage on to separate NGM agar plates. On reaching the 
adult stage, they were allowed to lay eggs for 2 hours, then 
the adults were removed. Eggs were allowed to develop at 
20ºC until the larvae reached adulthood and began to lay 
eggs. The developmental time for each worm was calculated 
from egg to egg-laying adult. 
Brood Size 
 L4 hermaphrodites of the desired genotype were 
transferred individually onto NGM agar plates at 20°C, and 
transferred to fresh plates at 24 hour intervals. The progeny 
were counted at late larval to adult stages by flaming worms 
one by one. An embryo was scored as being dead if the egg 
had not hatched after 24 hours at 20°C. The brood size for 
each animal was calculated as the sum of both hatched and 
non-hatched progeny. 
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Table 1. Transgenes and Gene Constructs 
 
No. Transgene and Integration Status  Gene Construct with Restriction Sites 
 1  Cerulean (C) Non-integrated  NcoI-Cerulean-SacI 
 2  Venus (V) Integrated   NcoI-Venus-SacI 
 3  Cerulean + Venus (C+V) Integrated  NcoI-Cerulean-SacI + NcoI-Venus-SacI 
 4  Cerulean-Venus Integrated NcoI-Cerulean-Csp45I/Csp45I-Venus-SacI 
 5  Synuclein + Venus Integrated NcoI-Synuclein-SacI/NcoI-Venus-SacI 
 6  Synuclein-Venus (SV) Non-integrated* NcoI-Synuclein-Csp45I + Csp45I-Venus-SacI 
 7  Synuclein-Venus + Synuclein-Cerulean Integrated NcoI-Synuclein-Csp45I/Csp45I-Venus-SacI + NcoI-Synuclein-Csp45I/Csp45I-Cerulean-SacI 
List of all the transgenes expressed in C. elegans using the unc-54 promoter. Restriction enzymes were added to cut these gene constructs and various combinations used for 
construction of gene-fusions as indicated in the table. The genes were cloned into pGEMT-easy plasmid and sub-cloned into pET30a and subsequently into pPD30.38 (Fire lab 
vector, Addgene; http://www.addgene.org/firelab/ ) incorporating the unc-54 promoter site. A slash (/) designates fusion of the sequences indicated, whereas a plus sign (+) indicates 
a mixture of both sequences. The integration status of each strain is indicated in the second column. *Although our own unc-54::SV strain was non-integrated, a very similar 
construct is fully integrated in strain NL5901. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Schematic representation of the cloning and sub-cloning of -synuclein fused with Venus (YFP). All other fusion transgenes were 
created in a similar fashion. 
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Pharyngeal Pumping Rate 
 Pharyngeal pumping rates were determined by picking 10 
adult worms from the bacterial lawn on an NGM agar plate 
and transferring them onto a bacteria-free plate, since it was 
difficult to observe pharyngeal pumping on food-containing 
agar plates as worms tend to hide under the bacteria. 
Pharyngeal pumping was observed for each of the 10 worms 
for 1 minute at room temperature (~ 20°C) using a dissection 
microscope (Olympus Model SZX12). 
Locomotion Rate 
 Locomotion rates were measured by picking individual 
adult worms from an NGM agar plate with bacteria and 
transferring them onto a bacteria-free plate. The number of 
bends performed by each worm over a 30 second interval 
was then determined. 10 such worms were measured for 
each strain at room temperature (~ 20°C), using a dissection 
microscope as above. 
Lifespan 
 The lifespan of worms was determined by picking 
individual hermaphrodites at the late L4 stage onto separate 
plates. They were left for 2 hours to produce eggs, then the 
adults were removed. The eggs were allowed to develop at 
20ºC until larvae reached the L4 stage, when they were 
transferred onto a separate plate and incubated overnight at 
20ºC. Next day the adults were transferred onto a new plate 
leaving their offspring behind on the old plate. The same 
process was repeated until the worms stopped producing 
offspring (usually 3-4 days). The adult worms were allowed 
to grow on at 20ºC, and were monitored daily by tapping 
them on the head. Animals were considered dead if no 
movement was observed following repeated probing. Once 
worms were identified as dead, their lifespan was calculated 
from egg until death. 
FRET Analysis of Unc-54 :: SC+SV and SV Worms 
 SC+SV and SV worms were grown on 14 cm NGM 
plates for 4 days at 15ºC and synchronized by L1 filtration 
using a 5m mesh filter [29]. This crude method of 
synchronization was chosen in preference to the standard 
method of egg isolation by bleaching, in order to avoid 
possible confounding effects on -synuclein aggregation 
caused by treatment with toxic bleach (NaOCl). To monitor 
FRET signals during ageing, synchronized L4 larvae of both 
SC+SV and SV (NL5901 [12]) strains were washed 
repeatedly with K medium [28] and worm numbers counted. 
Worm suspensions were diluted as necessary to equalize 
worm numbers between the strains and time points 
compared, and were stirred continuously during dispensing 
[20]. At least 4 replicate 300 l aliquots (each containing 
1000 to 1500 worms) were placed in separate U-bottomed 
wells in 96-well non-fluorescent black plastic plates (Nunc 
Ltd, from Fisher Scientific, Loughborough, UK) and kept on 
ice for 10-15 min to allow worms to settle at the bottom of 
each well. Plates were read in a Perkin-Elmer Victor 1420 
Multi-Label Reader (< 2 min per plate), using narrow 
bandpass filters at 430 nm for CFP excitation and at 530 nm 
for YFP emission (total FRET). For determinations of CFP, 
excitation was at 430 nm and emissions read at 486 nm; for 
YFP determinations, excitation was at 510 nm and emissions 
read at 530 nm. All three fluorescence readings were taken in 
rapid succession for each well. At the conclusion of the 
FRET measurements, worms of both strains were collected 
by centrifugation and cultured on standard NGM agar plates, 
with L1 filtration [29] on each of 4 successive days so as to 
remove offspring, returning the adults to the culture plates 
each time. A second set of FRET measurements was 
undertaken for both strains on day 6 of adult life. We have 
obtained essentially identical results (data not shown) using 
non-reproducing cultures of worms maintained from L4 
onwards on NGM plates containing 200 M 
fluorodeoxyuridine (FUdR) to maintain synchronicity 
without reproduction [30]. Based on the cross-over between 
CFP and YFP channels measured for worms expressing unc-
54::C (non-integrated) or unc-54::SV (NL5901, integrated; 
[12]), a corrected net FRET value was calculated according 
to the following formula: 
Corrected net FRET = total FRET - [(0.45  CFP reading) + 
(0.07  YFP reading)]. 
 For CFP-only worms (C), the total FRET signal was 45% 
of the measured CFP fluorescence. Although this unc-54::C 
strain is non-integrated, its transgene is transmitted with high 
efficiency to ~80% of progeny. Worms were grown up for 1 
generation only from picked fluorescent L4 larvae. 
 For YFP-only worms (NL5901), the total FRET signal 
was only 7% of the measured YFP fluorescence. Note that 
our own unc-54::SV strain is non-integrated, but like unc-
54::C (above) transmits its transgene to ~80% of its progeny. 
However, strain NL5901 was used for Figs. (4-6). 
 FRET signals are given in Relative Fluorescence Units, 
which are directly comparable only within the same strain 
and run. However, percentage changes relative to an L4 
baseline are robust to changes in worm number, and are very 
reproducible from one run to another (data not shown). 
Confocal Microscopy of SC+SV and SV+C Worms 
 For confocal microscopy, worms were removed from the 
microplate wells and immobilized in a final concentration of 
10 mM sodium azide and 50% (v/v) glycerol. After 
mounting on slides and sealing the coverslips with nail 
polish, confocal microscopy was performed using a Leica 
TCS SP2 Confocal Laser Scanning Microscope; CFP 
excitation used a laser set at 458 nm with an emission range 
from 465 to 600 nm, whereas YFP excitation used a 514 nm 
laser with an emission range from 525 to 600 nm. YFP 
emissions (525-600 nm) were also examined after CFP 
excitation at 458 nm, providing a FRET image with no 
detectable cross-over from the CFP channel (see Fig. 5c). 
YFP fluorescence was also examined in unc-54::SC+SV 
worms both at day 1 and day 6 adult stages; controls 
included non-integrated CFP-expressing unc-54::C and unc-
54::SV+C strains. 
Statistical Analysis 
 Mean data from all the assays (except life span and 
FRET) were analysed using one-way ANOVA followed by 
Dunnett’s multiple comparisons test against wild-type N2 as 
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control. Since lifespan was calculated as percentage survival, 
the data were analysed using a Mantel-Cox log rank test. For 
the FRET analysis, unpaired t-tests were used. 
RESULTS 
Egg to Adult Development Time 
 All strains took between 70 and 80 hours to reach 
adulthood (Fig. 2a). One-way ANOVA revealed no 
significant effect of strain (F = 1.031, p = 0.448; Table 2), 
and Dunnett‘s multiple comparison test against N2 controls 
confirmed that none of the transgenic strains tested differed 
from N2 in terms of developmental time (p > 0.05). 
Brood Size 
 One-way ANOVA showed no statistical difference between 
strains for brood size (F = 0.326, p = 0.938, Table 2), which for 
all strains was close to 300, confirming that they were all 
normal [31]. There was also no statistically significant 
difference between transgenic strains (with or without -
synuclein) and N2 controls (p > 0.05, Dunnett’s test) (Fig. 2b). 
Pharyngeal Pumping Rate 
 Transgenic -synuclein-expressing worms showed 
slower pharyngeal pumping rates when compared with the 
transgenic strains lacking -synuclein or with wild type N2 
worms. One-way ANOVA showed a significant strain effect 
(F = 8.06, p < 0.0001, Table 2). Using Dunnett‘s multiple 
comparisons test, the transgenic -synuclein-expressing 
worms (S+V, SV and SC+SV) were found to be significantly 
different (p < 0.05, p < 0.001 and p < 0.001, respectively) 
from the control wild-type N2 worms, whereas the 
transgenic strains lacking -synuclein (V, CV and C+V) 
were not (p > 0.05 in all cases) (Fig. 2c). 
Locomotion Rate 
 One-way ANOVA revealed a significant effect of strain 
on locomotion rate (F = 21.76, p < 0.0001, Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). (a) Egg to adult development time, (b) Brood size, (c) Pharyngeal pumping rate and (d) Locomotion rate for the various transgenic 
worm strains tested. Error bars show the standard error of the mean. All trangenic strains were integrated lines, apart from C and SV which 
were both non-integrated lines showing high transmission (~80%) of the transgene to progeny. 
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Transgenic -synuclein-expressing worms moved more 
slowly than transgenic strains lacking -synuclein, or wild 
type N2 worms. Using Dunnett‘s multiple comparisons test, 
the transgenic -synuclein-expressing worms (S+V, SV and 
SC+SV) were statistically significantly different (p < 0.001 
for all 3 strains) from control wild-type N2 worms, whereas 
the strains lacking -synuclein (V, CV and C+V) were not (p 
> 0.05) (Fig. 2d). 
Lifespan 
 As shown in Fig. (3a), the 3 lines expressing one or both 
fluorescent markers but lacking -synuclein (V, CV and 
C+V) showed only a slight (1-2 days) reduction in lifespan 
compared to N2 worms at 20 °C, which was non-significant 
(p = 0.08, 0.137 and 0.555, respectively; Mantel-Cox test). 
This is consistent with other studies, which showed that 
expression of GFP reporters does not in itself affect lifespan 
significantly [32]. However, as shown in Fig. (3b), the 3 
lines expressing -synuclein (S+V, SV and SC+SV) all 
showed a marked decrease of ~5 days in lifespan as 
compared to N2 (p < 0.0001 for all 3 strains; Mantel-Cox 
test). Thus over-expression of -synuclein in these worms 
caused significant toxicity and reduced lifespan, as well as 
the reduced motility and pharyngeal pumping noted earlier 
(Fig. 2c, d). 
 
Table 2.  
 
 Trait  MS  df  F  p  N2 Control (Mean ± SD) 
Egg to adult development time 9.881  7  1.031  0.448 74 ± 3 hours 
Brood size 320.1  7  0.326  0.938 284.2 ± 45.7 eggs 
Pharyngeal pumping rate 1305  6  8.061 < 0.0001 195.8 ± 5.2 pumps/min 
Locomotion rate 85.28  6  21.76 < 0.0001 14.2 ± 1.5 bends/min 
Summary of One-Way ANOVA tests performed on egg to adult development time, brood size, pharyngeal pumping rate and locomotion rate, where strain was treated as a fixed 
factor. Units of analysis and mean N2 control values (± SD) are shown in the final column 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Lifespans of (a) non-synuclein and (b) -synuclein expressing transgenic worms, calculated as the percentage left alive on each day. 
I = integrated strain; NI = non-integrated SV strain (only fluorescent worms were selected for the lifespan analysis). 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). (a) Corrected net FRET signal of L4 and day 6 SC+SV worms and (b) YFP signal of L4 and day 6 NL5901 (SV) worms. Error bars 
show the standard error of the mean. 
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Fig. (5). Confocal Microscopy: (a) unc-54::SC+SV worms (I) showing FRET signal with CFP excitation, (b) control unc-54::C worms (NI) 
showing the absence of FRET signal under identical conditions and (c) the head region of a young adult unc-54::SV+C worm (NI) showing 
diffuse CFP but aggregated YFP. The excitation and emission wavelengths used were 458/485 nm for CFP, and 514/545 nm for YFP. All 
photographs used the same gain settings and exposure times; scale bars =100μm. Each part [(a), (b) and (c)] shows images of the same 
worm, using CFP fluorescence [(a)i, (b)i, (c)i], FRET [(a)ii, b(ii)], CFP fluorescence with YFP excitation [(a)iv, (b)iv] or YFP fluorescence 
[(a)v, (b)v, (c)ii]. Differential interference contrast (DIC) images of the same worms are shown in panels (a)iii, (a)vi, (b)iii and (b)vi. I = 
integrated strain. NI = non-integrated strain. 
972      CNS & Neurological Disorders - Drug Targets, 2012, Vol. 11, No. 8 Bodhicharla et al. 
FRET Analysis of SC+SV Worms 
 The corrected net FRET data for doubly transgenic unc-
54::SC + unc-54::SV (henceforward unc-54::SC+SV) worms 
were analysed using unpaired t-tests, which showed that net 
FRET significantly increased with age (t = 12.45, p < 
0.0001). We simultaneously measured reporter gene 
expression changes using unc-54::SV (NL5901 [12]) worms, 
and found some increase in YFP expression also (t = 2.87, p 
= 0.02). However, the increase in net FRET was 
proportionately much larger than the increase in unc-54 
reporter expression (82% increase versus 31%), thus 
indicating an apparent increase in -synuclein aggregation 
with age (Fig. 4a, b). 
Confocal Microscopy 
 Confocal microscopy of SC+SV worms with excitation at 
458 nm showed a strong CFP signal but also robust FRET 
(Fig. (5a) i and ii). When excited at 514 nm, the worms 
showed no CFP signal but strong YFP fluorescence (as 
expected; Fig. (5a) iv and v). Worms expressing only CFP 
(unc54::C) showed fluorescence only in the CFP emission 
range, but no FRET (Fig. (5b) i and ii); moreover, no 
fluorescence was apparent in either channel using YFP 
excitation at 514 nm (Fig. (5b) iv and v). This control 
confirmed that the YFP signal seen with CFP excitation in 
SC+SV worms (Fig. (5a) ii) is genuine FRET rather than 
cross-over from CFP emissions into the YFP emission range. 
Cross-over from YFP signals into the CFP channel was 
minimal (see Methods). In Fig. (5c), the head of an unc-
54::SV+C worm (non-integrated line) showed strongly 
granular YFP but diffuse expression for CFP (compare Fig. 
(5c) i and ii), suggesting that the -synuclein moiety is 
essential for aggregation into these granular inclusions. 
 Confocal microscopy of SC+SV worms with Z-stacking 
showed that the distribution of granules for both CFP (Fig. 
6a) and YFP (Fig. 6b) was virtually coincident, using the 
same excitation lasers and emission filters as for Fig. (5) (i.e. 
with virtually no cross-over). Thus both SC and SV 
transgenes were abundantly expressed, and even small 
granules contained both fluorescent tags. A comparison 
between 1-day and 6-day adult worms suggested an increase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Confocal microscopy of unc-54:: SC+SV L4 and adult worms (I). Body wall muscles of worms with Z-stacking for CFP (part a) 
or YFP (parts b-d): (a) L4 larval head imaged for CFP (458 nm laser, 485 nm emission filter); (b) the same L4 head region imaged for YFP 
(514 nm laser, 545 nm emission filter); (c) 1-day old adult showing small YFP-labelled granules; (d) 6-day adult showing larger and more 
intense or merged YFP-labelled granules. The YFP excitation and emission wavelengths for parts c and d were the same as for part b. All 
images used the same exposure time and gain settings; scale bar =100μm. I = integrated strain. 
Synuclein Aggregation in C. elegans CNS & Neurological Disorders - Drug Targets, 2012, Vol. 11, No. 8     973 
in these granular inclusions with age. At 1 day (Fig. 6c), the 
granules of aggregated -synuclein were mostly small, but 
these increased in size and intensity or merged by day 6 of 
adult life (Fig. 6d). These findings reinforced the conclusion 
from the FRET measurements in Fig. (4), indicating that -
synuclein aggregation increased over time during the first 6 
days of adult life. 
DISCUSSION 
 Previous transgenic C. elegans models involving unc-54-
driven GFP- or YFP-tagged -synuclein constructs expressed in 
C. elegans body-wall muscle have been used mainly for 
hypothesis-driven [11] or genome-wide [12] RNAi screening to 
identify genetic modifiers of -synuclein aggregation. These 
have relied essentially on image analysis to identify genes 
whose inactivation increases (or decreases) the 
number/size/intensity of fluorescent granules within the test 
worms. Inevitably, there is an element of interpretation here, 
which might result in some false positives or negatives; 
moreover, results may be influenced by factors that modify 
transgene expression levels or cause small aggregates to 
coalesce. Lastly, the toxic species of aggregated -synuclein are 
most likely small oligomers rather than the larger granular 
inclusions which are screened for. In all of these respects, there 
are clear advantages to be gained from developing a FRET-
based quantitative assay using doubly transgenic SC+SV worms 
expressing both CFP and YFP-tagged -synucleins in the same 
cells (body-wall muscle, driven by the unc-54 promoter). Bulk 
fluorescence changes reflecting altered transgene expression or 
the spatial distribution of fluorescence can be controlled for by 
running parallel assays on the freely available NL5901 unc-
54::SV strain [12]. Moreover, increases in FRET signal might 
be detectable during -synuclein oligomerisation without any 
accompanying increase in fluorescent granule formation, since 
FRET could occur within small oligomers so long as both CFP 
and YFP fluorophores are present together in close proximity. It 
is reassuring to note that in vitro aggregation studies using YFP-
tagged -synuclein demonstrate that aggregation is not greatly 
impeded by the presence of the larger YFP moiety [21]; 
furthermore, the in vivo aggregation of this same fusion protein 
expressed in NL5901 worms is greatly exacerbated by RNAi 
against both hsp-70 and hip-1 [33]. The limitations of currently 
available C. elegans models and advantages of our unc-
54::SC+SV strain are summarized in Table 3. 
 
 This study reports the development of an unc-54::SC+SV 
strain which fulfils most of these aims. Broadly speaking, the 
overexpressed -synuclein fusion proteins formed 
fluorescent granular inclusions throughout the body-wall 
muscle, similar to those reported previously for the unc-
54::SV strain NL5901 [12]. These granules increased in size 
and intensity in older worms, consistent with recent reports 
that widespread protein aggregation accompanies normal 
ageing in C. elegans [34]. There were also clear adverse 
effects of -synuclein overexpression on several life-history 
parameters, including lifespan, motility and pharyngeal 
pumping rate, though not on brood size or developmental 
time. A transgenic strain overexpressing wild-type or mutant 
-synuclein only in neurons (using the aex-3 or dat-1 
promoter) showed an increased lifespan partly attributable to 
caloric restriction as a result of decreased pharyngeal 
pumping, as well as decreased egg-laying [35]. In our unc-
54::SC+SV strain, the reduction in pharyngeal pumping (< 
20%) was much less than the reduction in overall motility 
(~50%), consistent with the fact that the SV and SC 
transgenes are expressed in body-wall but not in pharyngeal 
muscle cells. Overall, any effect of reduced feeding on 
lifespan is likely to be outweighed by other detrimental 
effects of -synuclein overexpression in our SC+SV and 
other S-expressing worms. 
 Notably, the adverse effects on life-history traits reported 
in this study were confined to those strains expressing an -
synuclein construct, whereas no significant effects were 
observable in strains similarly overexpressing the CFP or 
YFP fluorescent markers. This strongly suggests that the 
fluorescent granules in unc-54::SC+SV worms resulted from 
aggregation of the attached -synuclein moieties. Moreover, 
in an unc-54::SV+C strain, the CFP fluorescence remained 
diffuse while the YFP was strongly granular, again 
suggesting that aggregation was dependent on -synuclein, 
and did not simply result from overexpressed proteins 
aggregating randomly. 
 It might be thought preferable to develop C. elegans 
models expressing such fluorescent-tagged -synuclein 
constructs either pan-neuronally or even in the dopaminergic 
neurons only [13]. Although we have prepared a similar set 
of fusion constructs attached to the pan-neuronal aex-3 
promoter, we chose to start by deliberately overexpressing 
these fusion proteins throughout the body-wall muscle, so as 
to generate strong fluorescent signals where genuine FRET 
Table 3. Summary of Advantages and Drawbacks of C. elegans Models for Parkinson’s Disease 
 
 SC+SV NL 5901 Pdat-1 : WT and A53T and Paex-3:WT and A53T 
Expression Body-wall muscle cells 
(unc-54) 
Body-wall muscle cells (unc-
54) 
Either pan-neuronally (aex-3) or only in 
dopaminergic neurons (dat-1) 
Gene expression and RNAi studies? Yes Yes Yes 
Strong signal (reflecting higher 
expression levels)? 
Yes Yes No (better for aex-3 than dat-1, which is 
expressed in 5 dopaminergic cells) 
Relevance to human Parkinson’s 
disease? 
Limited to synuclein 
aggregation  
Limited to synuclein 
aggregation 
Yes (construct expressed in neuronal cells).  
Quantification of aggregation? Yes (using FRET) Indirect (requires image 
analysis) 
Indirect (requires image analysis) 
High-throughput? Yes (using FRET) No (requires image analysis) No (requires image analysis) 
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could be distinguished both from background noise and from 
the inevitable cross-over between CFP and YFP channels. 
We believe that our unc-54::SC+SV strain will prove useful 
for identifying environmental risk factors that might 
contribute to the development of human Parkinson’s disease 
– particularly since the majority of cases are idiopathic rather 
than genetic [6, 7] in origin. Moreover, our SC+SV strain 
can readily be used for high-throughput screening (through 
simple quantitative FRET measurements), allowing mixtures 
of agents to be tested (Table 3). The interactions between 
environmental and genetic (explored via RNAi) factors can 
also be studied using this strain, with positive hits confirmed 
through careful comparison against control strains (e.g. 
NL5901; Fig. 4). Lastly, given that fluorescent granules are 
already apparent in L4 larvae and increase during adult life 
(Fig. 6), this strain readily lends itself to the screening of 
anti-aggregation drug candidates. However, because of the 
muscle site of transgene expression, this model is unlikely to 
respond to drug interventions targeting dopaminergic 
functions specifically, except perhaps through general effects 
on oxidative stress. 
ABBREVIATIONS 
A30P and A53T = Mutant versions of Synuclein leading to  
   familial Parkinson’s disease. 
aex-3 = C. elegans gene expressed pan- 
   neuronally 
C = Cerulean (CFP) 
CFP = Cyan (blue) Fluorescent Protein 
CGC = Caenorhabditis Genetics Center  
   (University of Minnesota) 
C-terminus = carboxy terminus of protein 
CV = CFP sequence fused at its carboxy  
   terminus to YFP sequence 
dat-1 = C. elegans gene expressed in  
   dopaminergic neurons only 
FRET = Foerster Resonance Energy Transfer 
FUdR = Fluorodeoxyuridine 
GFP = Green Fluorescent Protein 
hsp-70 and hip-1 = Genes implicated in dealing with  
   protein aggregates in C. elegans 
I = Integrated transgenic strain 
K medium = C. elegans saline (53 mM NaCl, 32 mM  
   KCl) 
L1 to L4 = larval stages of C. elegans 
N2 = Wild-type (Bristol) strain of C. elegans 
NGM = Nematode Growth Medium 
NI = Non-Integrated transgenic strain 
NL5901 = An unc-54::SV transgenic strain  
   available from CGC 
PCR = Polymerase Chain Reaction 
phe-glu = Dipeptide sequence (phenylalanine  
   followed by glutamic acid) introduced  
   by cloning 
RFU = Relative Fluorescence Units 
RNAi = RNA interference 
S = Human Synuclein coding sequence 
SD = Standard Deviation 
SEM = Standard Error of Mean 
SC = Human Synuclein coding sequence  
   fused at its C terminus to CFP 
SV = Human Synuclein coding sequence  
   fused at its C terminus to YFP 
unc-54 = Promoter sequence from major muscle  
   myosin gene in C. elegans 
(unc-54::)C = C. elegans carrying a (non-integrated)  
   unc-54-regulated CFP (C) transgene 
(unc-54::)C+V = C. elegans carrying both unc-54- 
   regulated CFP and unc-54-regulated  
   YFP transgenes 
(unc-54::)S+V = C. elegans carrying both unc-54- 
   regulated S and unc-54-regulated YFP  
   transgenes 
(unc-54::)SC+SV = C. elegans carrying both unc-54- 
   regulated SC and unc-54-regulated SV  
   transgenes 
(unc-54::)SV = C. elegans carrying an unc-54-regulated  
   SV transgene 
(unc-54::)SV+C = C. elegans carrying both unc-54- 
   regulated SV and unc-54-regulated CFP  
   transgenes 
V = Venus (YFP) 
YFP = Yellow Fluorescent Protein 
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